← All trials
NCT06877533
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 7, 2025
- Primary completion
- Jul 10, 2025
- Completion date
- Jul 10, 2025
- First posted
- Mar 14, 2025
- Last posted
- Aug 12, 2025
- Enrollment
- 3
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- iTeos TherapeuticsLead sponsor
- iTeos TherapeuticsOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.